Damora Therapeutics, Inc. (DMRA)
30.74
+0.43
(+1.42%)
USD |
NASDAQ |
Aug 25, 16:00
30.74
0.00 (0.00%)
After-Hours: 18:23
Damora Therapeutics Market Cap : 1.898B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.872B |
| August 21, 2026 | 1.903B |
| August 20, 2026 | 1.872B |
| August 19, 2026 | 2.003B |
| August 18, 2026 | 1.964B |
| August 17, 2026 | 1.920B |
| August 14, 2026 | 1.917B |
| August 13, 2026 | 1.898B |
| August 12, 2026 | 1.914B |
| August 11, 2026 | 1.875B |
| August 10, 2026 | 1.824B |
| August 07, 2026 | 1.848B |
| August 06, 2026 | 1.845B |
| August 05, 2026 | 1.860B |
| August 04, 2026 | 1.811B |
| August 03, 2026 | 1.723B |
| July 31, 2026 | 1.749B |
| July 30, 2026 | 1.762B |
| July 29, 2026 | 1.709B |
| July 28, 2026 | 1.775B |
| July 27, 2026 | 1.776B |
| July 24, 2026 | 1.738B |
| July 23, 2026 | 1.760B |
| July 22, 2026 | 1.809B |
| July 21, 2026 | 1.990B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.990B |
| July 17, 2026 | 1.899B |
| July 16, 2026 | 1.824B |
| July 15, 2026 | 1.867B |
| July 14, 2026 | 1.869B |
| July 13, 2026 | 1.689B |
| July 10, 2026 | 1.721B |
| July 09, 2026 | 1.857B |
| July 08, 2026 | 1.661B |
| July 07, 2026 | 1.810B |
| July 06, 2026 | 1.798B |
| July 02, 2026 | 1.808B |
| July 01, 2026 | 1.634B |
| June 30, 2026 | 1.569B |
| June 29, 2026 | 1.460B |
| June 26, 2026 | 1.530B |
| June 25, 2026 | 1.361B |
| June 24, 2026 | 1.327B |
| June 23, 2026 | 1.384B |
| June 22, 2026 | 1.441B |
| June 18, 2026 | 1.281B |
| June 17, 2026 | 1.292B |
| June 16, 2026 | 1.242B |
| June 15, 2026 | 1.211B |
| June 12, 2026 | 1.253B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.264B |
| Alnylam Pharmaceuticals, Inc. | 32.09B |
| Anika Therapeutics, Inc. | 288.00M |
| Savara, Inc. | 1.148B |
| Vericel Corp. | 2.209B |
Market Cap Related Metrics
| PEG Ratio | -0.0003 |
| Price to Book Value | 4.917 |
| Price | 30.74 |
| Earnings Yield | -405.9% |
| PEGY Ratio | -0.0003 |